FDA may ditch some TV ad requirements

Share this article:

The FDA is rethinking just how many side effects need to be talked about in television ads.

The LA Times reports that the regulator is surveying 1,500 participants to see just how much information they take in and understand when watching advertisements.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.